Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Yu Wang, Baocheng Deng
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 629-652
Closed Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
cPDS Promotes Cell Apoptosis by Reducing the Translational Efficiency of BIRC3 mRNA in HCC
Yiheng Liu, Qingqing Liu, Tianyi Huang, et al.
Digestive Diseases and Sciences (2025)
Open Access | Times Cited: 1
Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
Hui Shao, Jingyan Chen, Ali Li, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 8, pp. 5217-5237
Open Access | Times Cited: 17
SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance
Tian-Ze Li, Jianwei Yi, Hua‐Jun Wu, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 2326-2342
Open Access | Times Cited: 7
Kaempferol from Alpinia officinarum hance induces G2/M cell cycle arrest in hepatocellular carcinoma cells by regulating the ATM/CHEK2/KNL1 pathway
Xiaoliang Li, Mingyan Zhou, Zhe Zhu, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118430-118430
Closed Access | Times Cited: 7
Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review)
Honglian Yu, Qiang Bian, Xin Wang, et al.
Oncology Reports (2024) Vol. 51, Iss. 3
Open Access | Times Cited: 6
Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 19, pp. 2512-2522
Open Access | Times Cited: 6
Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors
Chunxun Liu, Haoran Zhao, Rujia Zhang, et al.
Oncology Letters (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 16
β‐Sitosterol suppresses hepatocellular carcinoma growth and metastasis via FOXM1‐regulated Wnt/β‐catenin pathway
Yuankun Chen, Yijun Yang, Nengyi Wang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 13
The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma
Xuejing Wang, Xiaojun Wang
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Research progress on natural products against hepatocellular carcinoma
LINGLI ZHANG, Yan Li, Jingxin Mao
Biocell (2024) Vol. 48, Iss. 6, pp. 905-922
Open Access | Times Cited: 5
Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma
Yumin Wang, Joshua S Fleishman, Jinhua Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116878-116878
Open Access | Times Cited: 5
New and Old Key Players in Liver Cancer
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 12
Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma
Qi Huang, Xin Zhong, Jing Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116409-116409
Open Access | Times Cited: 4
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma
Hanyuan Liu, Chunmei Wang, Ruiqiang Wang, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 167-194
Open Access | Times Cited: 4
T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma
Chaobo Chen, Zheng Chen, Zheyu Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2
Nana Zhou, Chaoqin Guo, Xiangyu Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116473-116473
Open Access | Times Cited: 4
Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma
Jiacheng Liu, Yaowei Bai, Xiaoming Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Surface-Enhanced Raman Scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins
Jinxin Sheng, Ri Wang, Haifan Yang, et al.
Photodiagnosis and Photodynamic Therapy (2024) Vol. 49, pp. 104336-104336
Open Access | Times Cited: 4
Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma
Xiaoli Zhang, ­Jun Li­, Yichen Yao, et al.
Journal of Gastroenterology (2025)
Closed Access
Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC
Lei Jin, Hongyuan Dai, Ya Zhang, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
A novel ubiquitination-related gene signature for overall survival prediction in patients with liver hepatocellular carcinoma
Xiuyun Chen, Senlin Li, Lixue Cao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top